Cemiplimab Found to Be Viable Treatment for Cutaneous Squamous-Cell Carcinoma

By Sahil Rawal ‘19 Cutaneous squamous-cell carcinoma is one of the most common skin cancers, and approximately 8500 people died from it as recently as 2012. A majority of patients who are diagnosed with this type of cancer are cured by surgery, but a small percent of patient are not because of metastasis or the tumor being unaffected by surgery. Since some of the markers … Continue reading Cemiplimab Found to Be Viable Treatment for Cutaneous Squamous-Cell Carcinoma

Caption: Glioblastoma cells stained for GFAP proteins.

New Study Shows that Sinomenine Hydrochloride Inhibits Human Glioblastoma Cell Growth

By Melvin Li ’20 Glioblastomas are among the most malignant brain tumors. People diagnosed with them, typically do not have many options for treatment due to the tumors’ abilities to resist apoptosis, or cell death. The tumors tend to grow quickly and are very aggressive; due to the amount of blood supplied to the brain, tumor cells get ample nutrients and growth factors to proliferate. … Continue reading New Study Shows that Sinomenine Hydrochloride Inhibits Human Glioblastoma Cell Growth